Correlation Between Ascendis Pharma and BeiGene

Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and BeiGene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and BeiGene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ascendis Pharma AS and BeiGene, you can compare the effects of market volatilities on Ascendis Pharma and BeiGene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of BeiGene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and BeiGene.

Diversification Opportunities for Ascendis Pharma and BeiGene

0.02

Correlation Coefficient

Ascendis Pharma  BeiGene

Significant diversification

The 3 months correlation between Ascendis and BeiGene is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and BeiGene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BeiGene and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with BeiGene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BeiGene has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and BeiGene go up and down completely randomly.

Pair Corralation between Ascendis Pharma and BeiGene

Assuming the 90 days trading horizon Ascendis Pharma AS is expected to generate 0.7 times more return on investment than BeiGene. However, Ascendis Pharma AS is 1.43 times less risky than BeiGene. It trades about 0.18 of its potential returns per unit of risk. BeiGene is currently generating about -0.08 per unit of risk. If you would invest  4,884  in Ascendis Pharma AS on September 24, 2024 and sell it today you would earn a total of  451.00  from holding Ascendis Pharma AS or generate 9.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ascendis Pharma AS  vs.  BeiGene

Ascendis Pharma AS

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Ascendis Pharma AS are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Ascendis Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

BeiGene

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BeiGene has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, BeiGene is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Ascendis Pharma and BeiGene

The main advantage of trading using opposite Ascendis Pharma and BeiGene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, BeiGene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BeiGene will offset losses from the drop in BeiGene's long position.

The idea behind Ascendis Pharma AS and BeiGene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.